Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $13.6 million.

  • AC Immune's Total Non-Current Liabilities fell 1004.56% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year decrease of 1004.56%. This contributed to the annual value of $20.3 million for FY2024, which is 9979.02% down from last year.
  • Per AC Immune's latest filing, its Total Non-Current Liabilities stood at $13.6 million for Q3 2025, which was down 1004.56% from $19.9 million recorded in Q2 2025.
  • Over the past 5 years, AC Immune's Total Non-Current Liabilities peaked at $10.9 billion during Q2 2021, and registered a low of $2.0 million during Q3 2022.
  • Over the past 5 years, AC Immune's median Total Non-Current Liabilities value was $15.0 million (recorded in 2024), while the average stood at $2.8 billion.
  • In the last 5 years, AC Immune's Total Non-Current Liabilities tumbled by 9998.18% in 2022 and then surged by 17067736.49% in 2023.
  • Quarter analysis of 5 years shows AC Immune's Total Non-Current Liabilities stood at $10.2 billion in 2021, then crashed by 99.94% to $5.7 million in 2022, then skyrocketed by 170677.36% to $9.7 billion in 2023, then crashed by 99.79% to $20.3 million in 2024, then crashed by 33.1% to $13.6 million in 2025.
  • Its last three reported values are $13.6 million in Q3 2025, $19.9 million for Q2 2025, and $19.0 million during Q1 2025.